Litigation Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LLC (D.N.J. 2015)
✉ Email this page to a colleague
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LLC (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-11-29 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-07-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 8,247,425; 8,420,663; 8,552,025; 8,822,490; 9,180,125 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LLC (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-02-17 | 7 | United States Patent Nos. 8,247,425 (“the ’425 patent”); 8,420,663 (“the ’663 patent”); 8,552,025 (“…. 021964, the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and ’125 patent are listed in the FDA…expiration of the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and ’125 patent or such later date…expiration of the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and ’125 patent or such later date…expiration of the ’425 patent, ’663 patent, ’025 patent, ’490 patent, and ’125 patent; 9. declare | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
